Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Net Cash Flow (2018 - 2026)

Alector's (ALEC) quarterly Net Cash Flow came in at -$17.0 million in Q2 2026, down 350.76% year-over-year from $6.8 million in Q2 2025, and down 252.75% quarter-over-quarter from $11.2 million in Q1 2026.

Analysis

Alector (ALEC) Net Cash Flow (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Net Cash Flow for 9 consecutive years, with -$17.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Cash Flow fell 350.76% year-over-year to -$17.0 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 712.13% increase from a year earlier, with the FY2025 full-year figure at $32.8 million, up 179.5% from the prior year.
  • Net Cash Flow was -$17.0 million for Q2 2026 at Alector, down from $11.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $125.5 million in Q1 2022 and troughed at -$282.4 million in Q2 2022.
  • A 5-year average of -$14.9 million and a median of -$7.1 million in 2024 frame the typical range for Net Cash Flow.
  • Across the five-year window, Net Cash Flow slumped 1981.11% in 2022 and jumped 405.53% in 2025, its largest moves.
  • Over 5 years, Net Cash Flow stood at -$29.9 million in 2022, then advanced by 8.36% to -$27.4 million in 2023, then surged by 86.0% to -$3.8 million in 2024, then slumped by 178.82% to -$10.7 million in 2025, then plunged by 59.3% to -$17.0 million in 2026.
  • The last three Net Cash Flow figures came in at -$17.0 million (Q2 2026), $11.2 million (Q1 2026), and -$10.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -496,000.00
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -2.09 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -37.14 Mn
10 Alector 274.68 Mn 101.88 Mn - -17.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.05 Mn
Mar 31, 2026 11.16 Mn
Dec 31, 2025 -10.70 Mn
Sep 30, 2025 31.73 Mn
Jun 30, 2025 6.80 Mn
Mar 31, 2025 4.95 Mn
Dec 31, 2024 -3.84 Mn
Sep 30, 2024 -10.39 Mn
Jun 30, 2024 -25.01 Mn
Mar 31, 2024 -2.00 Mn
Dec 31, 2023 -27.41 Mn
Sep 30, 2023 -29.58 Mn
Jun 30, 2023 -63.94 Mn
Mar 31, 2023 41.23 Mn
Dec 31, 2022 -29.91 Mn
Sep 30, 2022 11.97 Mn
Jun 30, 2022 -282.36 Mn
Mar 31, 2022 125.47 Mn
Dec 31, 2021 -187.38 Mn
Sep 30, 2021 390.82 Mn